Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Talon: Assessing Marqibo's FDA Odds
TheStreet.com
Tuesday, March 13, 2012 - 11:45am
tags:
Talon Therapeutics, Marqibo, FDA, leukemia
Omeros gains as eye drug meets late-stage trial goal
Reuters
Tuesday, March 13, 2012 - 11:44am
tags:
Omeros, OMS302
Galena Looks Undervalued Considering Cancer Therapy Results
Seeking Alpha
Tuesday, March 13, 2012 - 11:38am
tags:
Galena Biopharma, NeuVax
Allergan wins injunction against Botox alternative
Pharma Times, UK
Tuesday, March 13, 2012 - 11:29am
tags:
Botox, Allergan, Merz, Xeomin
FDA warns Warner Chilcott on Puerto Rico plant violations
Reuters
Tuesday, March 13, 2012 - 11:25am
tags:
FDA, Warner Chilcott, Puerto Rico, warnings, drug manufacturing
Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
Seeking Alpha
Tuesday, March 13, 2012 - 11:25am
tags:
Cel-Sci, Teva Pharmaceuticals, Multikine, head and neck cancer
Don't Expect Too Much From New Pain Drugs, Analyst Says
Forbes
Tuesday, March 13, 2012 - 11:07am
tags:
painkillers, NGF blockers, Amgen, Regeneron, JNJ
The Secret Reason Merck's Earnings Are Awesome
Motley Fool
Tuesday, March 13, 2012 - 11:06am
tags:
Merck, earnings
AstraZeneca files lawsuit against FDA regarding Seroquel
Yahoo/Fly on the Wall
Tuesday, March 13, 2012 - 11:06am
tags:
FDA, Seroquel, lawsuits, AstraZeneca
Novo Advances as Pfizer Drops Diabetes Deal
Bloomberg
Tuesday, March 13, 2012 - 11:05am
tags:
Novo Nordisk, Biocon, insulin, Pfizer, diabetes
Abbott Surging To $80, Shocking Naysayers
Seeking Alpha
Tuesday, March 13, 2012 - 11:04am
tags:
Abbott Laboratories, Merck, Pfizer, GeoVax Labs, Pharma-Bio Serv
Biocon Plunges After Ending Pfizer Insulin Distribution Pact
Bloomberg
Tuesday, March 13, 2012 - 11:03am
tags:
Pfizer, Biocon, insulin, diabetes
Arena Pharma's 5-Year Revenue Forecast
Seeking Alpha
Monday, March 12, 2012 - 8:44pm
tags:
Arena Pharmaceuticals
Vical's Allovectin: Why Hasn't The Trial Been Stopped?
Seeking Alpha
Monday, March 12, 2012 - 8:44pm
tags:
Vical, Allovectin, metastatic melanoma, melanoma, Zytiga, JNJ
Bristol-Myers CEO Gets 27% Pay Increase After Cancer Drug Sales Start Fast
Bloomberg
Monday, March 12, 2012 - 8:42pm
tags:
Bristol-Myers Squibb, Pharma CEOs, executive pay, Lamberto Andreotti
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk
Yahoo/AP
Monday, March 12, 2012 - 5:47pm
tags:
FDA, painkillers, Pfizer, JNJ, Regeneron, arthritis
J&J Said to Face Demand to Raise Risperdal Accord Offer by $800 Million
Bloomberg
Monday, March 12, 2012 - 5:45pm
tags:
JNJ, Risperdal
India licenses generic copy of patented Bayer drug
Yahoo/AP
Monday, March 12, 2012 - 5:45pm
tags:
Bayer, generics, India, liver cancer, kidney cancer, sorefinib, Natco
Keeping an Eye on Merck's Intangibles
Motley Fool
Monday, March 12, 2012 - 5:35pm
tags:
Merck
What Will Pfizer Do With its Animal Health Business?
Yahoo/Wall St Cheat Sheet
Monday, March 12, 2012 - 5:34pm
tags:
Pfizer, animal health

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.